Re:Blood Oxygen Monitoring Returning to Apple Watch in the US
by snitty on Friday August 15, 2025 @07:25AM
(#44910993)
>The correct analogy would be a watch market dominated by Casio and Swatch with no independent smaller brands.
You've left out a Richemont Group, LVMH Group, Rolex, Patek, and dozens of independent brands, like Fears, Farer, Ochs and Junior, Czapek, Konstantin Chakin, FP Journe, Moser, FP Journe, MB&F, Richard Mille, and more.
EDIT: And Seiko.
Re:Blood Oxygen Monitoring Returning to Apple Watch in the US
by lovich on Friday August 15, 2025 @03:32PM
(#44916531)
> Poaching IP
I disagree with this framing where offering more money to employees is described with the same words used to describe stealing property
> smaller company
I mean, ok yea that’s technically true, but Masimo makes billions a year in revenue. They are not a smol bean company
Of course in Apple's case this Masimo story is not the only monopolistic practice.
The correct analogy would be a watch market dominated by Casio and Swatch with no independent smaller brands.
Because every smaller brand that becomes somewhat successful is bought out by the Big Two. Or never gets that far because new IP somehow ends up being the sole property of the Big Two through various other means.
(Technically an oligopoly, but still maintained by monopolistic lock-ins and actions.)